Hot-kugulitsa High Quality CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine/ Monoisopropanolamine (MIPA)

Timakhulupilira nthawi zonse kuti khalidwe la munthu limasankha zinthu zamtengo wapatali, tsatanetsatane wake amasankha zinthu zapamwamba kwambiri, pamodzi ndi mzimu WOONA, WABWINO NDI WOPHUNZITSA wa gulu laogwira ntchito pa Hot-selling High Quality CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine/ Monoisopropanolamine (MIPA), Tiyesetsa kuyesetsa kuthandiza ogula akunyumba ndi apadziko lonse lapansi, ndikupanga phindu limodzi ndikupambana-kupambana mgwirizano pakati pathu.tikuyembekezera mwachidwi mgwirizano wanu moona mtima.
Timakhulupilira nthawi zonse kuti umunthu wa munthu umasankha zamtundu wapamwamba kwambiri, tsatanetsatane wake amasankha zamtundu wapamwamba kwambiri, limodzi ndi mzimu wa REALISTIC, WOPHUNZITSA NDIPONSO WABWINOChina Mipa and Monoisopropanolamine, Timagwirizanitsa mapangidwe, kupanga ndi kutumiza kunja pamodzi ndi antchito aluso oposa 100, machitidwe okhwima olamulira khalidwe ndi luso lamakono.Timasunga ubale wamalonda wautali ndi ogulitsa ndi ogulitsa kupanga mayiko oposa 50, monga USA, UK, Canada, Europe ndi Africa etc.

3'-Amino-2'-hydroxy--[1,1'-bipheny] -3-carboxylic acid amagwiritsidwa ntchito ngati wapakatikati wa Eltrombopag.
Eltrombopag, yopangidwa ndi GlaxoSmithKline (GSK) ku UK ndipo pambuyo pake idapangidwa limodzi ndi Novartis ku Switzerland, ndiye woyamba komanso wovomerezeka wa agonist ang'onoang'ono omwe si peptide TPO receptor agonist padziko lapansi.Eltrombopag idavomerezedwa ndi US FDA mu 2008 pochiza idiopathic thrombocytopenic purpura (ITP), komanso mu 2014 pochiza aplastic anemia (AA).Ndiwonso mankhwala oyamba ovomerezedwa ndi US FDA pochiza AA m'zaka 30 zaposachedwa.
Mu december2012, US FDA inavomereza Eltrombopag zochizira thrombocytopenia odwala matenda a chiwindi C (CHC), kuti odwala matenda a chiwindi C ndi osauka matenda chifukwa otsika kupatsidwa zinthu za m`mwazi kuwerenga akhoza kuyamba ndi kusunga interferon zochokera muyezo mankhwala kwa matenda a chiwindi.Pa february3, 2014, GlaxoSmithKline adalengeza kuti FDA idapereka chithandizo chamankhwala chopambana cha Eltrombopag pochiza hemopenia kwa odwala omwe ali ndi chemicalbook aplastic anemia (SAA) omwe sanayankhe mokwanira ku immunotherapy.Pa Ogasiti 24, 2015, US FDA idavomereza Eltrombopag kuti azichiza thrombocytopenia mwa akulu ndi ana azaka za 1 ndi kupitilira omwe ali ndi matenda osachiritsika a immune thrombocytopenia (ITP) omwe alibe yankho lokwanira ku corticosteroids, immunoglobulins kapena splenectomy.Pa january4, 2018, Eltrombopag idavomerezedwa kuti ilembedwe ku China kuti ichiritse primary immune thrombocytopenia (ITP).

Timakhulupilira nthawi zonse kuti khalidwe la munthu limasankha zinthu zamtengo wapatali, tsatanetsatane wake amasankha zinthu zapamwamba kwambiri, pamodzi ndi mzimu WOONA, WABWINO NDI WOPHUNZITSA wa gulu laogwira ntchito pa Hot-selling High Quality CAS 78-96-6 99% Amino-2-Propanol / Isopropanolamine/ Monoisopropanolamine (MIPA), Tiyesetsa kuyesetsa kuthandiza ogula akunyumba ndi apadziko lonse lapansi, ndikupanga phindu limodzi ndikupambana-kupambana mgwirizano pakati pathu.tikuyembekezera mwachidwi mgwirizano wanu moona mtima.
Kugulitsa kotenthaChina Mipa and Monoisopropanolamine, Timagwirizanitsa mapangidwe, kupanga ndi kutumiza kunja pamodzi ndi antchito aluso oposa 100, machitidwe okhwima olamulira khalidwe ndi luso lamakono.Timasunga ubale wamalonda wautali ndi ogulitsa ndi ogulitsa kupanga mayiko oposa 50, monga USA, UK, Canada, Europe ndi Africa etc.